NasdaqGS - Nasdaq Real Time Price USD
Insmed Incorporated (INSM)
65.71
-2.04
(-3.01%)
At close: 4:00:02 PM EDT
67.00
+1.29
+(1.96%)
After hours: 5:49:26 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 11 | 12 |
| Avg. Estimate | -1.3 | -1.35 | -5.05 | -3.52 |
| Low Estimate | -1.44 | -1.52 | -5.52 | -5.16 |
| High Estimate | -1.2 | -1.2 | -3.79 | -2.33 |
| Year Ago EPS | -1.94 | -1.27 | -5.57 | -5.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 19 | 18 |
| Avg. Estimate | 103.24M | 113.48M | 466.72M | 992.51M |
| Low Estimate | 98.7M | 106M | 441.1M | 845.97M |
| High Estimate | 107M | 118.44M | 512.3M | 1.41B |
| Year Ago Sales | 90.34M | 93.42M | 363.71M | 466.72M |
| Sales Growth (year/est) | 14.28% | 21.47% | 28.32% | 112.66% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.23 | -1.25 | -1.16 | -1.36 |
| EPS Actual | -1.94 | -1.27 | -1.32 | -1.42 |
| Difference | -0.71 | -0.02 | -0.16 | -0.06 |
| Surprise % | -58.20% | -1.91% | -13.32% | -4.22% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.3 | -1.35 | -5.05 | -3.52 |
| 7 Days Ago | -1.37 | -1.4 | -5.32 | -3.52 |
| 30 Days Ago | -1.37 | -1.4 | -5.31 | -3.52 |
| 60 Days Ago | -1.36 | -1.4 | -5.32 | -3.37 |
| 90 Days Ago | -1.34 | -1.27 | -4.47 | -2.46 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 2 | 1 |
| Up Last 30 Days | 3 | 2 | 2 | 2 |
| Down Last 7 Days | -- | 2 | 2 | -- |
| Down Last 30 Days | 2 | 2 | 3 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INSM | 33.08% | -6.17% | 9.39% | 30.30% |
| S&P 500 | 13.17% | 3.05% | 8.05% | 13.75% |
Upgrades & Downgrades
| Initiated | Jefferies: Buy | 5/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/12/2025 |
| Maintains | UBS: Buy to Buy | 5/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/22/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/20/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 3/19/2025 |
Related Tickers
CYTK Cytokinetics, Incorporated
30.61
-4.73%
NUVL Nuvalent, Inc.
71.42
-3.00%
RVMD Revolution Medicines, Inc.
39.95
-4.61%
CRNX Crinetics Pharmaceuticals, Inc.
30.95
-7.11%
RYTM Rhythm Pharmaceuticals, Inc.
56.79
-3.69%
ARGX argenx SE
542.47
-3.29%
ALNY Alnylam Pharmaceuticals, Inc.
266.86
-1.23%
APLS Apellis Pharmaceuticals, Inc.
17.28
-1.37%
ACLX Arcellx, Inc.
58.25
-2.10%
PCVX Vaxcyte, Inc.
30.05
-4.87%